Advanced Search:
Equity Index Forex Crypto Commodity

GSK - GlaxoSmithKline

$40.66  -0.14 (-0.34%)

Updated: 03:17 May 5, 2024 EST

Next Hour's AI Forecast

98.1%

Avg. Accuracy (AI)

$43.28

Next Session's AI Forecast

97.85%

Avg. Accuracy (AI)

$41.81

Next Week's AI Forecast

100%

Trend's Accuracy (AI)

$40.95

GlaxoSmithKline's Position Within the Drug Manufacturers—General Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

GLAXOSMITHKLINE - HISTORICAL DATA 6M

  • Last price

    $ 40.66

  • Daily change

    $ -0.14

  • Previous Close

    $ 40.8

  • Last Updated

    03:17 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.69 0.31 0.1 0.22 0.09

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.77 0.89 0.77 0.78 0.86

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
66.67% 98.07% 98.82% 96.98%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
43.8 4.56% 41.89 0.75% 41.58 5.61% 39.37

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.2 57.08 5.57 16.67

GlaxoSmithKline Technical Analysis News

GlaxoSmithKline

980 Great West Road
Middlesex
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
https://www.gsk.com

Sectors: Healthcare
Industry: Drug Manufacturers—General
F. Time Employees: 70212
Description

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate Governance

GSK plc’s ISS Governance QualityScore as of May 1, 2024 is 9. The pillar scores are Audit: 10; Board: 5; Shareholder Rights: 1; Compensation: 9.

GLAXOSMITHKLINE'S HOLDERS RANK

List of holders with stock participation in GlaxoSmithKline.

Holder Rank Holder Shares Date Reported % Out Value